Association of serum uric acid and coronary artery disease in premenopausal women.

OBJECTIVE: To date, no study in the published literature has investigated the role of various serum uric acid (SUA) concentrations in the development of angiographically-proven coronary artery disease (CAD) in premenopausal women. Therefore, the aim of this study was to investigate the role SUA leve...

Full description

Bibliographic Details
Main Authors: Jian-wei Zhang, Ling-jie He, Shu-jun Cao, Qing Yang, Shi-wei Yang, Yu-jie Zhou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4153543?pdf=render
_version_ 1818924908249350144
author Jian-wei Zhang
Ling-jie He
Shu-jun Cao
Qing Yang
Shi-wei Yang
Yu-jie Zhou
author_facet Jian-wei Zhang
Ling-jie He
Shu-jun Cao
Qing Yang
Shi-wei Yang
Yu-jie Zhou
author_sort Jian-wei Zhang
collection DOAJ
description OBJECTIVE: To date, no study in the published literature has investigated the role of various serum uric acid (SUA) concentrations in the development of angiographically-proven coronary artery disease (CAD) in premenopausal women. Therefore, the aim of this study was to investigate the role SUA levels may play in the prevalence, severity, and prognosis of CAD in premenopausal women. METHODS: This cross-sectional retrospective study included 607 premenopausal women who had undergone coronary angiography. The CAD diagnosis was based upon stenosis affecting ≥ 50% of the luminal diameter. Association of the SUA levels with CAD prevalence, severity, and clinical outcomes were assessed by statistical analysis. RESULTS: In total, 369 (60.8%) of the patients were diagnosed with CAD. The CAD patients had significantly higher SUA levels than those without CAD (5.3 ± 1.9 vs. 4.8 ± 1.7 mg/dL, P = 0.001). The SUA levels were found to be significantly associated with CAD prevalence (P = 0.013). Patients with higher levels of SUA also showed increased rates of multivessel disease and composite end-points, such as major adverse cardiac events. Furthermore, multivariate analysis identified abnormally high levels of uric acid (hyperuricemia) as an independent risk factor for CAD (OR 1.51 (1.11-2.53), P<0.05). CONCLUSIONS: The SUA levels are significantly associated with the prevalence of CAD. The SUA levels may be a predictor for incidence of major cardiovascular events in premenopausal women.
first_indexed 2024-12-20T02:32:48Z
format Article
id doaj.art-e5e5afde93044498a738e5de405f99cb
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T02:32:48Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e5e5afde93044498a738e5de405f99cb2022-12-21T19:56:31ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10613010.1371/journal.pone.0106130Association of serum uric acid and coronary artery disease in premenopausal women.Jian-wei ZhangLing-jie HeShu-jun CaoQing YangShi-wei YangYu-jie ZhouOBJECTIVE: To date, no study in the published literature has investigated the role of various serum uric acid (SUA) concentrations in the development of angiographically-proven coronary artery disease (CAD) in premenopausal women. Therefore, the aim of this study was to investigate the role SUA levels may play in the prevalence, severity, and prognosis of CAD in premenopausal women. METHODS: This cross-sectional retrospective study included 607 premenopausal women who had undergone coronary angiography. The CAD diagnosis was based upon stenosis affecting ≥ 50% of the luminal diameter. Association of the SUA levels with CAD prevalence, severity, and clinical outcomes were assessed by statistical analysis. RESULTS: In total, 369 (60.8%) of the patients were diagnosed with CAD. The CAD patients had significantly higher SUA levels than those without CAD (5.3 ± 1.9 vs. 4.8 ± 1.7 mg/dL, P = 0.001). The SUA levels were found to be significantly associated with CAD prevalence (P = 0.013). Patients with higher levels of SUA also showed increased rates of multivessel disease and composite end-points, such as major adverse cardiac events. Furthermore, multivariate analysis identified abnormally high levels of uric acid (hyperuricemia) as an independent risk factor for CAD (OR 1.51 (1.11-2.53), P<0.05). CONCLUSIONS: The SUA levels are significantly associated with the prevalence of CAD. The SUA levels may be a predictor for incidence of major cardiovascular events in premenopausal women.http://europepmc.org/articles/PMC4153543?pdf=render
spellingShingle Jian-wei Zhang
Ling-jie He
Shu-jun Cao
Qing Yang
Shi-wei Yang
Yu-jie Zhou
Association of serum uric acid and coronary artery disease in premenopausal women.
PLoS ONE
title Association of serum uric acid and coronary artery disease in premenopausal women.
title_full Association of serum uric acid and coronary artery disease in premenopausal women.
title_fullStr Association of serum uric acid and coronary artery disease in premenopausal women.
title_full_unstemmed Association of serum uric acid and coronary artery disease in premenopausal women.
title_short Association of serum uric acid and coronary artery disease in premenopausal women.
title_sort association of serum uric acid and coronary artery disease in premenopausal women
url http://europepmc.org/articles/PMC4153543?pdf=render
work_keys_str_mv AT jianweizhang associationofserumuricacidandcoronaryarterydiseaseinpremenopausalwomen
AT lingjiehe associationofserumuricacidandcoronaryarterydiseaseinpremenopausalwomen
AT shujuncao associationofserumuricacidandcoronaryarterydiseaseinpremenopausalwomen
AT qingyang associationofserumuricacidandcoronaryarterydiseaseinpremenopausalwomen
AT shiweiyang associationofserumuricacidandcoronaryarterydiseaseinpremenopausalwomen
AT yujiezhou associationofserumuricacidandcoronaryarterydiseaseinpremenopausalwomen